#United Kingdom #Radiotherapy #Leo Cancer Care #Crawley #Marie®

Leo Cancer Care's CE Mark Achievement for Marie®

Leo Cancer Care has made significant strides in cancer treatment with the recent CE marking of its flagship product, Marie®. This revolutionary vertical radiotherapy system is set to transform the way radiotherapy is delivered across Europe.

What Does the CE Marking Mean?

Receiving the CE mark indicates that Marie® meets the European Union's stringent safety and performance standards. This crucial approval legitimizes the innovative technology that has had success in clinical settings, primarily in the United States. Now, patients in Europe can expect a new standard of care in radiotherapy that prioritizes their comfort and health outcomes.

A Patient-Centric Approach

Traditionally, radiotherapy has required patients to lie flat during treatment, which can be uncomfortable and may limit the efficacy of the procedure. Marie® introduces a transformative approach that allows patients to be treated in an upright position. This revolutionary modification shifts the focus toward patient-centric care, offering both comfort and enhanced treatment protocols.

Stephen Towe, CEO of Leo Cancer Care, expresses excitement about this development, stating, "This is more than just a regulatory milestone; it signifies the moment when upright radiotherapy becomes a clinical reality for patients in Europe. Marie® redefines potential in cancer treatment by merging human-centered design with the flexibility needed for existing and evolving treatment modalities."

Enhancing Operational Efficiency

By permitting treatment while patients are upright, Marie® may simplify the design of treatment rooms and enhance the operational efficiency of cancer care centers. The architectural design of Marie® is independent of beam architecture, accommodating various particle therapy modalities. This flexibility means that healthcare providers can integrate emerging treatments into their workflows seamlessly.

Key Benefits of Marie®

• - Natural Patient Experience: Patients can receive treatment in a more comfortable position, potentially reducing anxiety and improving their overall experience.
• - Enhanced Treatment Capabilities: Marie® supports adaptive radiation therapy and online arc therapy protocols, expanding the tools available to clinicians for personalized treatment plans.
• - Greater Accessibility: With a design that accommodates facilities unable to implement traditional particle therapy systems, Marie® promises to broaden access to advanced cancer treatment.
• - Future-Proof Platform: The design of Marie® positions it as a forward-thinking solution adaptable to future innovations in radiotherapy.

A Collaborative Effort

Leo Cancer Care has partnered with leading institutions over the years to research and refine Marie®. The longstanding collaboration with Centre Léon Bérard, a renowned cancer care center in France, has been pivotal. The center plans to focus on advanced imaging and vertical positioning capabilities to maximize the effects of Marie®.

Future Installations in Europe

With the CE marking secured, installations of Marie® are set to commence at prominent cancer treatment facilities, beginning with the Centro Nazionale di Adroterapia Oncologica (CNAO) in Italy. The goal is to start treatments before the end of this year. Dr. Sandro Rossi, the Director-General of CNAO, noted, "The integration of LCC's vertical positioning system into our clinical workflow represents a transformative milestone for CNAO. Combining LCC's innovative technology with our horizontal multi-ion beam enhances treatment precision and fundamentally improves clinical productivity."

Conclusion

The CE marking for Marie® marks a pivotal moment not only for Leo Cancer Care but for patients across Europe who will benefit from this advanced radiotherapy solution. As they collaborate with leading oncology centers, Leo Cancer Care aims to accelerate the integration of vertical radiotherapy in clinical practice, combining precise treatment with an improved patient experience. The future of cancer treatment looks promising with Marie® leading the way.